Inferring tumour purity and stromal and immune cell admixture from expression data

Citations Over TimeTop 1% of 2013 papers

Abstract

Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.

Related Papers

• → Functional characterization of two stromal cell lines that support B lymphopoiesis.(1990)51 cited
• → STUDIES ON THE MECHANISMS FOR ACTION OF FIBROBLAST GROWTH FACTORS IN STROMAL CELLS OF HYPERPLASTIC HUMAN PROSTATE(1995)1 cited
• → [Effect of prostate peripheral zones stromal cells on the proliferation of prostate cells by overexpression of LMO2 gene].(2016)
• → Targeting stromal-derived Gremlin1 to control Multiple Myeloma disease development(2019)
• → Classification of muscle-invasive bladder cancer based on tumor stromal compartment(2020)